Need help finding what you are looking for?
Contact Us
PUBLISHER: Inkwood Research | PRODUCT CODE: 1130700
PUBLISHER: Inkwood Research | PRODUCT CODE: 1130700
Asia-pacific Contrast Enhanced Ultrasound Market Forecast 2022-2030
PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
KEY FINDINGS
The Asia-Pacific contrast enhanced ultrasound market is set to rise with a CAGR of 5.54% over the forecasting years of 2022 to 2030. The market growth of the region is facilitated by the lack of well-organized reimbursement policies boosting the demand for affordable procedures as well as the rapid improvement in healthcare expenditure, primarily in developing countries such as China and India.
MARKET INSIGHTS
The Asia-Pacific contrast enhanced ultrasound market growth evaluation covers the assessment of Taiwan, Australia & New Zealand, India, South Korea, Indonesia, China, Japan, Singapore, and Rest of Asia Pacific. Contrast ultrasound manufacturers are collaborating with domestic medical technology businesses in India for the purpose of marketing, distribution, and production of contrast agents. This cooperation helps overseas businesses in proliferating their sales and distribution networks as well. For example, SonoVue (Sulphur Hexafluoride UCA) was distributed in India owing to the partnership between Bracco Diagnostic Inc and Trivitron Healthcare, one of the industry leaders in the ultrasound sector in India.
On the other hand, India also has a poor health care system, which fuels the demand for cost-effective imaging techniques such as contrast enhanced ultrasonography. Presently, ultrasound services for legal health screenings are prevalent across the country, with more people expected to use ultrasound tests exclusively for medical purposes. Therefore, these factors are set to play an essential role in propelling the contrast enhanced ultrasound market growth in the Asia-Pacific over the forecast period.
COMPETITIVE INSIGHTS
Key players operating in the market are: Koninklijke Philips NV, Trivitron Healthcare Pvt Ltd, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 48381
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
- 1.1. STUDY OBJECTIVES
- 1.2. SCOPE OF STUDY
- 1.3. METHODOLOGY
- 1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
- 2.1. MARKET SIZE & ESTIMATES
- 2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
- 3.1. KEY DRIVERS
- 3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
- 3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
- 3.2. KEY RESTRAINTS
- 3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
- 3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
4. KEY ANALYTICS
- 4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
- 4.2. KEY MARKET TRENDS
- 4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
- 4.4. OPPORTUNITY MATRIX
- 4.5. VENDOR LANDSCAPE
- 4.6. VALUE CHAIN ANALYSIS
- 4.7. KEY BUYING CRITERIA
- 4.7.1. COST EFFICIENCY
- 4.7.2. PRODUCT FEATURES
- 4.7.3. END-USE
- 4.8. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
- 5.1. EQUIPMENT
- 5.2. CONTRAST AGENT
6. MARKET BY TYPE
- 6.1. NON-TARGETED
- 6.2. TARGETED
7. MARKET BY END-USER
- 7.1. HOSPITALS
- 7.2. CLINICS
- 7.3. AMBULATORY DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
- 8.1. ASIA-PACIFIC
- 8.1.1. MARKET ESTIMATES & SIZES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
- 8.1.5.1. CHINA
- 8.1.5.2. JAPAN
- 8.1.5.3. INDIA
- 8.1.5.4. SOUTH KOREA
- 8.1.5.5. INDONESIA
- 8.1.5.6. SINGAPORE
- 8.1.5.7. TAIWAN
- 8.1.5.8. AUSTRALIA & NEW ZEALAND
- 8.1.5.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
- 9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
- 9.2. COMPANY PROFILES
- 9.2.1. BAYER AG
- 9.2.2. BRACCO DIAGNOSTIC INC
- 9.2.3. DAIICHI SANKYO COMPANY LIMITED
- 9.2.4. GE HEALTHCARE
- 9.2.5. KONINKLIJKE PHILIPS NV
- 9.2.6. LANTHEUS MEDICAL IMAGING INC
- 9.2.7. NANOPET PHARMA GMBH
- 9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
- 9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
- 9.2.10. SIEMENS HEALTHINEERS AG
- 9.2.11. TAEJOON PHARM
- 9.2.12. TRIVITRON HEALTHCARE
Product Code: 48381
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
- 1.1. STUDY OBJECTIVES
- 1.2. SCOPE OF STUDY
- 1.3. METHODOLOGY
- 1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
- 2.1. MARKET SIZE & ESTIMATES
- 2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
- 3.1. KEY DRIVERS
- 3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
- 3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
- 3.2. KEY RESTRAINTS
- 3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
- 3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
4. KEY ANALYTICS
- 4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
- 4.2. KEY MARKET TRENDS
- 4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
- 4.4. OPPORTUNITY MATRIX
- 4.5. VENDOR LANDSCAPE
- 4.6. VALUE CHAIN ANALYSIS
- 4.7. KEY BUYING CRITERIA
- 4.7.1. COST EFFICIENCY
- 4.7.2. PRODUCT FEATURES
- 4.7.3. END-USE
- 4.8. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
- 5.1. EQUIPMENT
- 5.2. CONTRAST AGENT
6. MARKET BY TYPE
- 6.1. NON-TARGETED
- 6.2. TARGETED
7. MARKET BY END-USER
- 7.1. HOSPITALS
- 7.2. CLINICS
- 7.3. AMBULATORY DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
- 8.1. ASIA-PACIFIC
- 8.1.1. MARKET ESTIMATES & SIZES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
- 8.1.5.1. CHINA
- 8.1.5.2. JAPAN
- 8.1.5.3. INDIA
- 8.1.5.4. SOUTH KOREA
- 8.1.5.5. INDONESIA
- 8.1.5.6. SINGAPORE
- 8.1.5.7. TAIWAN
- 8.1.5.8. AUSTRALIA & NEW ZEALAND
- 8.1.5.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
- 9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
- 9.2. COMPANY PROFILES
- 9.2.1. BAYER AG
- 9.2.2. BRACCO DIAGNOSTIC INC
- 9.2.3. DAIICHI SANKYO COMPANY LIMITED
- 9.2.4. GE HEALTHCARE
- 9.2.5. KONINKLIJKE PHILIPS NV
- 9.2.6. LANTHEUS MEDICAL IMAGING INC
- 9.2.7. NANOPET PHARMA GMBH
- 9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
- 9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
- 9.2.10. SIEMENS HEALTHINEERS AG
- 9.2.11. TAEJOON PHARM
- 9.2.12. TRIVITRON HEALTHCARE
LIST OF TABLES
- TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT - CONTRAST ENHANCED ULTRASOUND
- TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS
- TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES
- TABLE 4: REGULATORY FRAMEWORK
- TABLE 5: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 6: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 13: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET
- TABLE 14: LIST OF MERGERS & ACQUISITIONS
- TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
- TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
- TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
- FIGURE 1: KEY MARKET TRENDS
- FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 3: OPPORTUNITY MATRIX
- FIGURE 4: VENDOR LANDSCAPE
- FIGURE 5: VALUE CHAIN ANALYSIS
- FIGURE 6: KEY BUYING CRITERIA
- FIGURE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
- FIGURE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
- FIGURE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
- FIGURE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
- FIGURE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 13: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
- FIGURE 14: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
- FIGURE 15: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
- FIGURE 16: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
- FIGURE 17: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
- FIGURE 18: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 19: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 20: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 21: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 22: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 23: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 24: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 25: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 26: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
LIST OF FIGURES
- FIGURE 1: KEY MARKET TRENDS
- FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 3: OPPORTUNITY MATRIX
- FIGURE 4: VENDOR LANDSCAPE
- FIGURE 5: VALUE CHAIN ANALYSIS
- FIGURE 6: KEY BUYING CRITERIA
- FIGURE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
- FIGURE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
- FIGURE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
- FIGURE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
- FIGURE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 13: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
- FIGURE 14: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
- FIGURE 15: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
- FIGURE 16: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
- FIGURE 17: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
- FIGURE 18: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 19: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 20: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 21: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 22: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 23: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 24: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 25: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 26: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.